Posts

Targeted Protein Degradation Market: AI, PROTACs & Novel Therapeutics Creating New Opportunities

Image
  Market Overview According to MarketGenics, the global Targeted Protein Degraders Market was valued at USD 0.3 billion in 2025 and is projected to reach USD 1.4 billion by 2035 , expanding at a CAGR of 17.4% during the forecast period. The market is gaining strong momentum as targeted protein degradation enables the selective removal of disease-causing proteins, including previously difficult-to-drug targets. Proteolysis Targeting Chimeras (PROTACs) accounted for the major share of the market at approximately 72% , supported by extensive clinical development, pharmaceutical investment, and growing validation across therapeutic applications. To obtain a free sample research report - https://marketgenics.co/download-report-sample/targeted-protein-degradation-market-50576 Market Growth Drivers Key growth drivers include the rising demand for therapies targeting previously undruggable proteins , increasing clinical validation of PROTACs and molecular-glue degraders, and g...
Post a Comment
Read more

Asia-Pacific Biomarker Commercialization Market: Precision Medicine & Advanced Diagnostics Driving Innovation

Image
  Market Overview According to MarketGenics, the growing adoption of biomarkers across precision medicine, personalized healthcare, disease diagnosis, drug development, and clinical research is creating significant opportunities for biomarker commercialization. The Biomarker Commercialization Market is projected to grow from USD 36.2 billion in 2025 to USD 137.0 billion by 2035 , registering a CAGR of 14.2 % . These developments are accelerating opportunities for biomarker discovery, validation, companion diagnostics, clinical-trial applications, and commercialization of biomarker-based healthcare solutions. To obtain a free sample research report - https://marketgenics.co/download-report-sample/biomarker-commercialization-market-39446 Market Growth Drivers The market is being driven by the increasing adoption of precision medicine, personalized therapies, early disease detection, companion diagnostics, liquid biopsy, genomics, next-generation sequencing (NGS), AI-powere...
Post a Comment
Read more

Asia-Pacific Hospital AI Copilot Market: Generative AI & Healthcare Automation Creating New Opportunities

Image
  Market Overview According to the broader MarketGenics AI-copilot and healthcare AI landscape, Hospital AI Copilots are emerging as AI-powered assistants designed to support physicians, nurses, administrators, and other healthcare professionals across clinical and operational workflows. These solutions use generative AI, large language models, natural language processing, machine learning, and healthcare data integration to assist with clinical documentation, patient information retrieval, medical decision support, scheduling, administrative tasks, coding, care coordination, and workflow automation. The broader AI Copilot market is benefiting from rapid enterprise AI adoption, while healthcare represents an important vertical for applying conversational and workflow-based AI. To obtain a free sample research report - https://marketgenics.co/download-report-sample/hospital-ai-copilot-market-47233 Market Growth Drivers Key growth drivers include the increasing volume of c...
Post a Comment
Read more

Asia-Pacific Synthetic Clinical Data Market: Privacy-Preserving AI & Healthcare Data Innovation

Image
  Market Overview According to MarketGenics, the Synthetic Clinical Data Market is gaining importance as pharmaceutical companies, biotechnology firms, healthcare organizations, and research institutions increasingly adopt synthetic datasets for clinical research, healthcare analytics, and AI development. The market is part of the rapidly expanding synthetic-data ecosystem, where MarketGenics values the broader Synthetic Data Market at USD 0.5 billion in 2025 and projects it to reach USD 6.1 billion by 2035, registering a CAGR of 29.1% . Synthetic clinical data helps organizations generate realistic patient-level datasets while reducing dependence on sensitive real-world patient information, supporting clinical research, AI model training, clinical-trial simulation, and data sharing. To obtain a free sample research report - https://marketgenics.co/download-report-sample/synthetic-clinical-data-market-19118 Market Growth Drivers The market is being driven by the increasin...
Post a Comment
Read more

Medical AI Governance Market to Reach USD 1.9 Billion by 2035 at 21.7% CAGR: AI Safety, Regulatory Compliance & Responsible AI Driving Growth

  Market Overview According to MarketGenics, the global Medical AI Governance Market was valued at USD 0.3 billion in 2025 and is projected to reach USD 1.9 billion by 2035 , expanding at a CAGR of 21.7% . The market is gaining momentum as healthcare organizations increasingly deploy AI for diagnosis, clinical decision support, medical devices, patient monitoring, and administrative applications. Growing concerns around AI safety, model validation, transparency, accountability, cybersecurity, data privacy, bias mitigation, and lifecycle management are increasing the need for structured medical AI governance solutions. To obtain a free sample research report - https://marketgenics.co/download-report-sample/medical-ai-governance-market-98622 Market Growth Drivers Key growth drivers include the rapid adoption of AI and generative AI in healthcare , evolving regulatory and compliance requirements, and increasing demand for continuous AI performance monitoring. Healthcare or...
Post a Comment
Read more

Federated Healthcare AI Market to Reach USD 0.4 Billion by 2035 at 17.4% CAGR: Privacy-Preserving AI & Federated Learning Driving Growth

  Market Overview According to MarketGenics , the global Federated Healthcare AI Market was valued at USD 0.1 billion in 2025 and is projected to reach USD 0.4 billion by 2035 , expanding at a CAGR of 17.4% during the forecast period. The market is gaining momentum as healthcare organizations seek to develop and deploy AI models collaboratively while keeping sensitive patient data within their own institutional environments. Federated learning enables hospitals, research institutions, pharmaceutical companies, and other healthcare organizations to train AI models without centrally pooling patient records. The cross-silo federated learning segment holds the largest share, at approximately 79% , due to its suitability for multi-institutional healthcare collaboration. Key applications include medical imaging, disease diagnosis, clinical decision support, drug discovery, clinical research, predictive analytics, remote patient monitoring, and personalized medicine . To obtain a...
Post a Comment
Read more

Oral Biologics Market to Reach USD 16.9 Billion by 2035 at 16.4% CAGR: Oral Peptides & Advanced Drug Delivery Driving Growth

  Market Overview According to MarketGenics , the global Oral Biologics Market was valued at USD 3.7 billion in 2025 and is projected to reach USD 16.9 billion by 2035 , registering a CAGR of 16.4% during the forecast period. The peptides segment holds a major share of approximately 39% , supported by expanding oral peptide pipelines and growing adoption of oral GLP-1 therapies. The market is increasingly focused on converting injectable biologic therapies into convenient, non-injectable oral formulations , supported by advances in oral drug delivery, permeation enhancers, enteric coatings, lipid-based nanocarriers, nanoparticles, and ingestible delivery technologies . To obtain a free sample research report - https://marketgenics.co/download-report-sample/oral-biologics-market-26066 Market Growth Drivers The market is primarily driven by rising patient preference for convenient, needle-free biologic therapies , growing demand for chronic disease treatments, and increa...
Post a Comment
Read more